NCT01412034View on ClinicalTrials.gov

Effect of CER-001 on Plaque Volume in Homozygous Familial Hypercholesterolemia (HoFH) Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

August 31, 2014

Conditions
Homozygous Familial Hypercholesterolemia
Interventions
DRUG

CER-001

Biweekly infusion

Trial Locations (9)

11758

Clinical Research Facility, North Massapequa

100161

Clinical Research Facility, Rome

06102

Clinical Research Facility, Hartford

G7H 7P2

Clinical Research Facility, Chicoutimi

G1V4M6

Clinical Research Facility, Québec

1105AZ

Clinical Research Facility, Amsterdam

6229 HX

Clinical Research Facility, Maastricht

6500 HB

Clinical Research Facility, Nijmegen

M13 9WL

Clinical Research Facility, Manchester

Sponsors
All Listed Sponsors
lead

Cerenis Therapeutics, SA

INDUSTRY